In HFD-fed rats, nobiletin increased the levels of adiponectin and superoxide dismutase and alleviated hyperlipidemia and nonalcoholic fatty liver disease (NAFLD) [42]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.